Skip to main content

MW 616.8 Da, Purity >98%. Nonionic surfactant. Inhibits proliferation (IC50 values are 2, 5, 54, 61 and 66 for P. berghei. P. falciparum, HeLa, HepG2 and C. albicans respectively). Shows spermicidal, bacteriostatic and bactericidal effects in vivo. .

Be the first to review this product! Submit a review

Images

Chemical Structure - Nonoxynol-9 (N-9), Nonionic surfactant (AB143673), expandable thumbnail

Publications

Key facts

CAS number

14409-72-4

Purity

> 98%

Form

Liquid

Molecular weight

616.8 Da

Molecular formula

C33H60O10

PubChem identifier

72385

Nature

Synthetic

Alternative names

Recommended products

MW 616.8 Da, Purity >98%. Nonionic surfactant. Inhibits proliferation (IC50 values are 2, 5, 54, 61 and 66 for P. berghei. P. falciparum, HeLa, HepG2 and C. albicans respectively). Shows spermicidal, bacteriostatic and bactericidal effects in vivo. .

Key facts

Purity

> 98%

PubChem identifier

72385

Solubility

In water, 0.522 mg/L at 25 °C (est). Soluble in water, ethanol, ehtylene glycol, ethylene dichloride, xylene, corn oil. Insolulble in Stoddard solvent, deodorized kerosene, low viscosity white mineral oil. Solubility in water: moderate.

Biochemical name

Nonoxynol-9

Biological description

Nonionic surfactant. Inhibits proliferation (IC50 values are 2, 5, 54, 61 and 66 for P. berghei. P. falciparum, HeLa, HepG2 and C. albicans respectively). Shows spermicidal, bacteriostatic and bactericidal effects in vivo.

Canonical SMILES

CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

InChI=1S/C33H60O10/c1-2-3-4-5-6-7-8-9-32-10-12-33(13-11-32)43-31-30-42-29-28-41-27-26-40-25-24-39-23-22-38-21-20-37-19-18-36-17-16-35-15-14-34/h10-13,34H,2-9,14-31H2,1H3

InChIKey

FBWNMEQMRUMQSO-UHFFFAOYSA-N

IUPAC name

2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol

Storage

Shipped at conditions

Ambient - Can Ship with Ice

Appropriate short-term storage conditions

Ambient

Appropriate long-term storage conditions

Ambient

Storage information

The product can be stored for up to 12 months

Notes

This product is a colourless or light yellow viscous liquid at room temperature.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

OATP1B1 also known as SLCO1B1 is a solute carrier organic anion transporter protein with a mass of approximately 85 kDa. This protein operates mechanically by transporting endogenous compounds and xenobiotics such as drugs across liver cell membranes. The primary expression of OATP1B1 occurs in the liver specifically on the basolateral membrane of hepatocytes. This localization facilitates its essential role in hepatic uptake of a variety of substances playing a critical role in pharmacokinetics.

Biological function summary

OATP1B1 contributes prominently to drug metabolism and clearance. It actively transports diverse substrates including bile acids bilirubin and drugs such as statins. While not part of a larger complex OATP1B1 functions alongside other hepatic transporters to ensure efficient clearance and detoxification processes in the liver. The activity of OATP1B1 is fundamental for maintaining drug concentrations within therapeutic ranges thereby protecting against toxicity.

Pathways

OATP1B1 is part of the hepatic drug metabolic pathway and the bile acid synthesis pathway. It works in coordination with other transporters like OATP1B3 and NTCP which also mediate hepatic uptake of organic anions and bile acids. The interaction among these transporters regulates the systemic levels of endogenous compounds and the clearance of therapeutic drugs influencing their efficacy and safety profiles.

Associated diseases and disorders

OATP1B1 is linked to altered drug metabolism leading to statin-associated myopathy. Genetic variations in the OATP1B1 gene can reduce transporter function resulting in increased plasma concentration of statins which correlates with myopathy risk. Additionally OATP1B1 mutations may affect bilirubin handling contributing to conditions such as Rotor syndrome. Through these associations OATP1B1 interacts with other proteins affecting drug safety and disease states emphasizing its relevance in personalized medicine.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Chemical Structure - Nonoxynol-9 (N-9), Nonionic surfactant (ab143673), expandable thumbnail

    Chemical Structure - Nonoxynol-9 (N-9), Nonionic surfactant (ab143673)

    2D chemical structure image of ab143673, Nonoxynol-9 (N-9), Nonionic surfactant

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com